C. diff especially deadly for those with kidney disease, researchers find

Share this article:

People with end-stage renal disease (ESRD) have a significantly elevated risk of dying from Clostridium difficile infection, according to a recent study.

Researchers at Albert Einstein School of Medicine's Jacobi Medical Center in New York City compared outcomes of 104 ESRD patients on dialysis with a 300-person control group. They found those in the ESRD group had a C. diff-related mortality rate of 3.8%, while the other group's rate was 1.46%. ESRD patients were also more likely to have a relapse of severe C. diff infection within two months.

Combinining metronidazole and oral or rectal vancomycin was more effective than monotherapy drug treatment for the ESRD patients with C. diff, the researchers said. The monotherapy was associated with increased chances of a relapse, they found.

The research was released at the National Kidney Foundation 2013 Spring Clinical Meetings, held last week in Orlando, FL.

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.